180 related articles for article (PubMed ID: 17596650)
21. Altered ghrelin and peptide YY responses to meals in bulimia nervosa.
Kojima S; Nakahara T; Nagai N; Muranaga T; Tanaka M; Yasuhara D; Masuda A; Date Y; Ueno H; Nakazato M; Naruo T
Clin Endocrinol (Oxf); 2005 Jan; 62(1):74-8. PubMed ID: 15638873
[TBL] [Abstract][Full Text] [Related]
22. Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome.
Talebizadeh Z; Kibiryeva N; Bittel DC; Butler MG
Int J Mol Med; 2005 Apr; 15(4):707-11. PubMed ID: 15754036
[TBL] [Abstract][Full Text] [Related]
23. Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis.
Tauber M; Conte Auriol F; Moulin P; Molinas C; Delagnes V; Salles JP
Horm Res; 2004; 62(1):49-54. PubMed ID: 15192277
[TBL] [Abstract][Full Text] [Related]
24. Neural representations of hunger and satiety in Prader-Willi syndrome.
Hinton EC; Holland AJ; Gellatly MS; Soni S; Patterson M; Ghatei MA; Owen AM
Int J Obes (Lond); 2006 Feb; 30(2):313-21. PubMed ID: 16276365
[TBL] [Abstract][Full Text] [Related]
25. Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.
Butler MG; Carlson MG; Schmidt DE; Feurer ID; Thompson T
Am J Med Genet; 2000 Nov; 95(1):67-70. PubMed ID: 11074497
[TBL] [Abstract][Full Text] [Related]
26. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.
De Waele K; Ishkanian SL; Bogarin R; Miranda CA; Ghatei MA; Bloom SR; Pacaud D; Chanoine JP
Eur J Endocrinol; 2008 Oct; 159(4):381-8. PubMed ID: 18603572
[TBL] [Abstract][Full Text] [Related]
27. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
28. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.
Korner J; Bessler M; Cirilo LJ; Conwell IM; Daud A; Restuccia NL; Wardlaw SL
J Clin Endocrinol Metab; 2005 Jan; 90(1):359-65. PubMed ID: 15483088
[TBL] [Abstract][Full Text] [Related]
29. Fasting ghrelin levels are not elevated in children with hypothalamic obesity.
Kanumakala S; Greaves R; Pedreira CC; Donath S; Warne GL; Zacharin MR; Harris M
J Clin Endocrinol Metab; 2005 May; 90(5):2691-5. PubMed ID: 15769982
[TBL] [Abstract][Full Text] [Related]
30. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.
Butler MG; Bittel DC
Am J Med Genet A; 2007 Mar; 143A(5):415-21. PubMed ID: 17304548
[TBL] [Abstract][Full Text] [Related]
31. Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.
Sodowski K; Zwirska-Korczala K; Kuka D; Kukla M; Budziszewska P; Czuba B; Włoch A; Cnota W; Bielański W; Brzozowski T; Rehfeld JF; Zdun R; Konturek PC
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():37-52. PubMed ID: 17443026
[TBL] [Abstract][Full Text] [Related]
32. Hyperghrelinemia precedes obesity in Prader-Willi syndrome.
Feigerlová E; Diene G; Conte-Auriol F; Molinas C; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2008 Jul; 93(7):2800-5. PubMed ID: 18460565
[TBL] [Abstract][Full Text] [Related]
33. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
34. CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT).
Munsch S; Biedert E; Meyer AH; Herpertz S; Beglinger C
Physiol Behav; 2009 Apr; 97(1):14-20. PubMed ID: 19419677
[TBL] [Abstract][Full Text] [Related]
35. Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.
Goldstone AP; Thomas EL; Brynes AE; Castroman G; Edwards R; Ghatei MA; Frost G; Holland AJ; Grossman AB; Korbonits M; Bloom SR; Bell JD
J Clin Endocrinol Metab; 2004 Apr; 89(4):1718-26. PubMed ID: 15070936
[TBL] [Abstract][Full Text] [Related]
36. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?
Daousi C; MacFarlane IA; English PJ; Wilding JP; Patterson M; Dovey TM; Halford JC; Ghatei MA; Pinkney JH
J Clin Endocrinol Metab; 2005 Sep; 90(9):5025-30. PubMed ID: 15972581
[TBL] [Abstract][Full Text] [Related]
37. Protein meal-stimulated pancreatic polypeptide secretion in Prader-Willi syndrome of adults.
Tomita T; Greeley G; Watt L; Doull V; Chance R
Pancreas; 1989; 4(4):395-400. PubMed ID: 2668931
[TBL] [Abstract][Full Text] [Related]
38. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men.
Degen L; Drewe J; Piccoli F; Gräni K; Oesch S; Bunea R; D'Amato M; Beglinger C
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1391-9. PubMed ID: 17138722
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Dixon K
J Clin Endocrinol Metab; 1983 Nov; 57(5):1074-80. PubMed ID: 6352724
[TBL] [Abstract][Full Text] [Related]
40. Increased density of ghrelin-expressing cells in the gastric fundus and body in Prader-Willi syndrome.
Choe YH; Song SY; Paik KH; Oh YJ; Chu SH; Yeo SH; Kwon EK; Kim EM; Rha MY; Jin DK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5441-5. PubMed ID: 15956087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
